無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

電気生理学 (EP) アブレーションカテーテル:医療機器のパイプライン評価

Electrophysiology Ablation Catheters - Medical Devices Pipeline Assessment, 2018

発行 GlobalData 商品コード 404488
出版日 ページ情報 英文 133 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.36円で換算しております。
Back to Top
電気生理学 (EP) アブレーションカテーテル:医療機器のパイプライン評価 Electrophysiology Ablation Catheters - Medical Devices Pipeline Assessment, 2018
出版日: 2018年06月04日 ページ情報: 英文 133 Pages
概要

当レポートでは、世界の電気生理学 (EP) アブレーションカテーテルの市場における、主要なパイプライン製品 (医療機器) とその治験の進行状況について調査すると共に、製品特性の比較分析 (治験の進行段階別) や、主要企業のプロファイルおよび代表的製品、昨今の市場動静 (資本取引・事業提携など) といった情報を取りまとめてお届けいたします。

第1章 目次

第2章 イントロダクション

  • 前立腺がん診断検査の概要

第3章 現在治験中の製品

  • パイプライン製品:治験段階別
  • パイプライン製品:セグメント別
  • パイプライン製品:領域別
  • パイプライン製品:規制経路別
  • パイプライン製品:推定認証時期別
  • 現在進行中の治験

第4章 EPアブレーションカテーテル:各企業で現在治験中のパイプライン製品

  • EPアブレーションカテーテルの企業:治験段階別のパイプライン製品
  • EPアブレーションカテーテル:治験段階別のパイプライン製品

第5章 EPアブレーションカテーテルの企業・製品の概要

  • Advanced Cardiac Therapeutics, Inc.
    • パイプライン製品および進行中の治験の概要
  • Apama Medical, Inc.
  • Biosense Webster Inc
  • BioTex Inc
  • Boston Scientific Corp
  • Cardima, Inc. (Inactive)
  • CardioNova Ltd.
  • CathEffects LLC
  • CathRx Ltd
  • Cordis Corp
  • CryoTherapeutics Gmbh
  • Epicardial Technologies Inc
  • FocusStart LLC
  • Interventional Imaging, Inc.
  • Iowa Approach Inc.
  • Maestro Heart SA
  • Mayo Clinic US
  • Medlumics S.L.
  • Medtronic plc
  • MedWaves Incorporated
  • MicroPort Scientific Corporation
  • North Carolina State University
  • Northwestern University
  • Ra Medical Systems Inc
  • SCR, Inc.
  • St. Jude Medical Inc
  • Stereotaxis Inc
  • Strategic Polymer Sciences, Inc
  • University of Iowa
  • University of Michigan
  • University of Rochester
  • University of Texas Medical Branch at Galveston
  • Vanderbilt University
  • Vimecon GmbH
  • Vivonics, Inc.
  • Voyage Medical (Inactive)

第6章 EPアブレーションカテーテル市場:昨今の動向 (全47件)

第7章 提言

図表一覧

図表

List of Tables

1.1 List of Tables

  • Table 1: Electrophysiology Ablation Catheters - Pipeline Products by Stage of Development 10
  • Table 2: Electrophysiology Ablation Catheters - Pipeline Products by Segment 11
  • Table 3: Electrophysiology Ablation Catheters - Pipeline Products by Territory 12
  • Table 4: Electrophysiology Ablation Catheters - Pipeline Products by Regulatory Path 13
  • Table 5: Electrophysiology Ablation Catheters - Pipeline Products by Estimated Approval Date 14
  • Table 6: Electrophysiology Ablation Catheters - Ongoing Clinical Trials 15
  • Table 7: Electrophysiology Ablation Catheters Companies - Pipeline Products by Stage of Development 16
  • Table 8: Electrophysiology Ablation Catheters - Pipeline Products by Stage of Development 18
  • Table 9: Ablacon Inc Pipeline Products & Ongoing Clinical Trials Overview 20
  • Table 10: Ablasense - Product Status 20
  • Table 11: Ablasense - Product Description 20
  • Table 12: Advanced Cardiac Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
  • Table 13: ACT Cardiac Ablation Catheter - Product Status 21
  • Table 14: ACT Cardiac Ablation Catheter - Product Description 21
  • Table 15: Advanced Cardiac Therapeutics, Inc. - Ongoing Clinical Trials Overview 22
  • Table 16: ACT Cardiac Ablation Catheter - A Randomized Controlled Clinical Evaluation of the DiamondTemp System for the Treatment of Paroxysmal Atrial Fibrillation 23
  • Table 17: ACT Cardiac Ablation Catheter - Advanced Cardiac Therapeutics DiamondTemp Temperature-Controlled and Contact Sensing RF Ablation Clinical Trial for Atrial Fibrillation 23
  • Table 18: Apama Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 24
  • Table 19: Apama RF PVI Balloon Catheter System - Product Status 24
  • Table 20: Apama RF PVI Balloon Catheter System - Product Description 24
  • Table 21: Biosense Webster Inc Pipeline Products & Ongoing Clinical Trials Overview 25
  • Table 22: CARTO SMARTTOUCH 5D Catheter - Product Status 25
  • Table 23: CARTO SMARTTOUCH 5D Catheter - Product Description 25
  • Table 24: Next Generation Ablation Catheter - Product Status 26
  • Table 25: Next Generation Ablation Catheter - Product Description 26
  • Table 26: BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview 27
  • Table 27: Cooled Tip Catheter - Product Status 27
  • Table 28: Cooled Tip Catheter - Product Description 27
  • Table 29: Water-cooled Catheter - Product Status 28
  • Table 30: Water-cooled Catheter - Product Description 28
  • Table 31: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 29
  • Table 32: Cryo Balloon Catheter - Product Status 29
  • Table 33: Cryo Balloon Catheter - Product Description 29
  • Table 34: DirectSense Rx Catheter - Product Status 30
  • Table 35: DirectSense Rx Catheter - Product Description 30
  • Table 36: Force Sensing Afib Catheter - Product Status 30
  • Table 37: Force Sensing Afib Catheter - Product Description 30
  • Table 38: IntellaNav MiFi OI AF Ablation Catheter - Product Status 31
  • Table 39: IntellaNav MiFi OI AF Ablation Catheter - Product Description 31
  • Table 40: Next Generation Blazer Catheter - Product Status 31
  • Table 41: Next Generation Blazer Catheter - Product Description 32
  • Table 42: Next Generation IntellaTip Catheter - Product Status 32
  • Table 43: Next Generation IntellaTip Catheter - Product Description 32
  • Table 44: Boston Scientific Corp - Ongoing Clinical Trials Overview 33
  • Table 45: Next Generation IntellaTip Catheter - Microfidelity (MIFI) Ablation Technology Versus Standard Ablation Catheter for Atrioventricular Nodal Ablation A Comparative Pilot Study of Time to Success 34
  • Table 46: IntellaNav MiFi OI AF Ablation Catheter - Electrical Coupling Information from the Rhythmia HDx Mapping System and Direct Sense Technology in the Treatment of Paroxysmal Atrial Fibrillation - A Non-randomized, Prospective Study 35
  • Table 47: CardioFocus Inc Pipeline Products & Ongoing Clinical Trials Overview 36
  • Table 48: HeartLight Excalibur Balloon - Product Status 36
  • Table 49: HeartLight Excalibur Balloon - Product Description 36
  • Table 50: HeartLight X3 System - Product Status 37
  • Table 51: HeartLight X3 System - Product Description 37
  • Table 52: CardioFocus Inc - Ongoing Clinical Trials Overview 38
  • Table 53: HeartLight Excalibur Balloon - Clinical Study of the HeartLight X3 Endoscopic Ablation System (EAS) with Excalibur Balloon Compared to HeartLight System in the Treatment of Symptomatic Atrial Fibrillation 39
  • Table 54: HeartLight X3 System - Clinical Study of the HeartLight X3 Endoscopic Ablation System (EAS) with Excalibur Balloon Compared to HeartLight System in the Treatment of Symptomatic Atrial Fibrillation 40
  • Table 55: CardioNova Ltd Pipeline Products & Ongoing Clinical Trials Overview 41
  • Table 56: Electrophysiology Catheter - Atrial Fibrillation - Product Status 41
  • Table 57: Electrophysiology Catheter - Atrial Fibrillation - Product Description 41
  • Table 58: CathEffects LLC Pipeline Products & Ongoing Clinical Trials Overview 42
  • Table 59: Desai VectorCathRF1 Mapping And Ablation Catheter - Product Status 42
  • Table 60: Desai VectorCathRF1 Mapping And Ablation Catheter - Product Description 42
  • Table 61: CathRx Ltd Pipeline Products & Ongoing Clinical Trials Overview 43
  • Table 62: CathRx 4mm Therapeutic Catheter - Product Status 43
  • Table 63: CathRx 4mm Therapeutic Catheter - Product Description 43
  • Table 64: CathRx 8mm Therapeutic Catheter - Product Status 44
  • Table 65: CathRx 8mm Therapeutic Catheter - Product Description 44
  • Table 66: Khelix Irrigated Ablation EP Catheter - Product Status 44
  • Table 67: Khelix Irrigated Ablation EP Catheter - Product Description 45
  • Table 68: Khelix Non-Irrigated Ablation EP Catheter - Product Status 45
  • Table 69: Khelix Non-Irrigated Ablation EP Catheter - Product Description 45
  • Table 70: Cibiem Inc Pipeline Products & Ongoing Clinical Trials Overview 46
  • Table 71: Catheter-Based Carotid Body Ablation System - Product Status 46
  • Table 72: Catheter-Based Carotid Body Ablation System - Product Description 46
  • Table 73: Cibiem Inc - Ongoing Clinical Trials Overview 47
  • Table 74: Catheter-Based Carotid Body Ablation System - First-in-human Study for Ultrasound Based Endovascular Carotid Body Ablation in Subjects with Treatment-resistant Hypertension: A Safety and Feasibility Study 48
  • Table 75: Columbia University Pipeline Products & Ongoing Clinical Trials Overview 49
  • Table 76: Optically-Integrated RFA Catheter - Product Status 49
  • Table 77: Optically-Integrated RFA Catheter - Product Description 49
  • Table 78: Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 50
  • Table 79: EP Contact Force Sensing Catheter Enabled By CARTO 3 - Product Status 50
  • Table 80: EP Contact Force Sensing Catheter Enabled By CARTO 3 - Product Description 50
  • Table 81: CryoTherapeutics Gmbh Pipeline Products & Ongoing Clinical Trials Overview 51
  • Table 82: Cryotherapy System - Coronary Artery Disease - Product Status 51
  • Table 83: Cryotherapy System - Coronary Artery Disease - Product Description 51
  • Table 84: Epicardial Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 52
  • Table 85: Epicardial Access Device - Product Status 52
  • Table 86: Epicardial Access Device - Product Description 52
  • Table 87: FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview 53
  • Table 88: Anti-coagulum Cardiac Ablation Catheter - Product Status 53
  • Table 89: Anti-coagulum Cardiac Ablation Catheter - Product Description 53
  • Table 90: Interventional Imaging, Inc. Pipeline Products & Ongoing Clinical Trials Overview 54
  • Table 91: Atrial Fibrillation Catheter - Product Status 54
  • Table 92: Atrial Fibrillation Catheter - Product Description 54
  • Table 93: Iowa Approach Inc. Pipeline Products & Ongoing Clinical Trials Overview 55
  • Table 94: MaPP-CS - Product Status 55
  • Table 95: MaPP-CS - Product Description 55
  • Table 96: ROF-AC - Product Status 56
  • Table 97: ROF-AC - Product Description 56
  • Table 98: ROF-AS - Product Status 56
  • Table 99: ROF-AS - Product Description 57
  • Table 100: Maestro Heart SA Pipeline Products & Ongoing Clinical Trials Overview 58
  • Table 101: Maestro-AF Catheter System - Product Status 58
  • Table 102: Maestro-AF Catheter System - Product Description 58
  • Table 103: Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 59
  • Table 104: Pulmonary Vein Ablation Device - Product Status 59
  • Table 105: Pulmonary Vein Ablation Device - Product Description 59
  • Table 106: Medlumics SL Pipeline Products & Ongoing Clinical Trials Overview 60
  • Table 107: AblaView - Product Status 60
  • Table 108: AblaView - Product Description 60
  • Table 109: MedWaves Inc Pipeline Products & Ongoing Clinical Trials Overview 61
  • Table 110: Arrhythmia Catheters - Product Status 61
  • Table 111: Arrhythmia Catheters - Product Description 61
  • Table 112: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 62
  • Table 113: Circular Ablation Catheter - Product Status 62
  • Table 114: Circular Ablation Catheter - Product Description 62
  • Table 115: Voyager Irrigated RF Ablation Catheter - Product Status 63
  • Table 116: Voyager Irrigated RF Ablation Catheter - Product Description 63
  • Table 117: North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview 64
  • Table 118: Robotic Catheter - Product Status 64
  • Table 119: Robotic Catheter - Product Description 64
  • Table 120: Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 65
  • Table 121: Cardiac Catheter - Product Status 65
  • Table 122: Cardiac Catheter - Product Description 65
  • Table 123: Novasentis Inc Pipeline Products & Ongoing Clinical Trials Overview 66
  • Table 124: Electroactive Polymer Based Steerable Catheter - Product Status 66
  • Table 125: Electroactive Polymer Based Steerable Catheter - Product Description 66
  • Table 126: SCR, Inc. Pipeline Products & Ongoing Clinical Trials Overview 67
  • Table 127: Atrial Fibrillation Device - Product Status 67
  • Table 128: Atrial Fibrillation Device - Product Description 67
  • Table 129: Seattle Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview 68
  • Table 130: Ablation Catheter - Heart Arrhythmia - Product Status 68
  • Table 131: Ablation Catheter - Heart Arrhythmia - Product Description 68
  • Table 132: Sotera Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 69
  • Table 133: Sotera - Atrial Fibrillation Device - Product Status 69
  • Table 134: Sotera - Atrial Fibrillation Device - Product Description 69
  • Table 135: St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 70
  • Table 136: TactiCath Contact Force Ablation Catheter - Sensor Enabled - Product Status 70
  • Table 137: TactiCath Contact Force Ablation Catheter - Sensor Enabled - Product Description 70
  • Table 138: Stereotaxis Inc Pipeline Products & Ongoing Clinical Trials Overview 71
  • Table 139: Next Generation Irrigated Magnetic Catheter - Product Status 71
  • Table 140: Next Generation Irrigated Magnetic Catheter - Product Description 71
  • Table 141: University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 72
  • Table 142: Non-Contact Mapping Catheter - Product Status 72
  • Table 143: Non-Contact Mapping Catheter - Product Description 72
  • Table 144: University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 73
  • Table 145: RF Ablation Catheter - Product Status 73
  • Table 146: RF Ablation Catheter - Product Description 73
  • Table 147: University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 74
  • Table 148: Ablation Catheter - Product Status 74
  • Table 149: Ablation Catheter - Product Description 74
  • Table 150: Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 75
  • Table 151: Temperature Controlled Catheter - Product Status 75
  • Table 152: Temperature Controlled Catheter - Product Description 75
  • Table 153: Vimecon GmbH Pipeline Products & Ongoing Clinical Trials Overview 76
  • Table 154: Vimecon Laser CAI Catheter - Product Status 76
  • Table 155: Vimecon Laser CAI Catheter - Product Description 76
  • Table 156: Vimecon GmbH - Ongoing Clinical Trials Overview 77
  • Table 157: Vimecon Laser CAI Catheter - A Clinical Trial for the Assessment of the Safety and Performance of the Vimecon Laser Cardiac Ablation Instrument (CAI) for the Interventional Treatment of Paroxysmal Atrial Fibrillation (AF) 78
  • Table 158: Vivonics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 79
  • Table 159: Catheter Guidance System - Product Status 79
  • Table 160: Catheter Guidance System - Product Description 79
  • Table 161: Voyage Medical (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 80
  • Table 162: IRIS Ablation System - Product Status 80
  • Table 163: IRIS Ablation System - Product Description 80
  • Table 164: Glossary 132

List of Figures

1.2 List of Figures

  • Figure 1: Electrophysiology Ablation Catheters - Pipeline Products by Stage of Development 10
  • Figure 2: Electrophysiology Ablation Catheters - Pipeline Products by Segment 11
  • Figure 3: Electrophysiology Ablation Catheters - Pipeline Products by Territory 12
  • Figure 4: Electrophysiology Ablation Catheters - Pipeline Products by Regulatory Path 13
  • Figure 5: Electrophysiology Ablation Catheters - Pipeline Products by Estimated Approval Date 14
  • Figure 6: Electrophysiology Ablation Catheters - Ongoing Clinical Trials 15
目次
Product Code: GDME0566EPD

GlobalData's Medical Devices sector report, "Electrophysiology Ablation Catheters - Medical Devices Pipeline Assessment, 2018" provides an overview of Electrophysiology Ablation Catheters currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Electrophysiology Ablation Catheters pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Electrophysiology Ablation Catheters under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Electrophysiology Ablation Catheters and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Electrophysiology Ablation Catheters under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 5
  • 1.2 List of Figures 8

2 Introduction 9

  • 2.1 Electrophysiology Ablation Catheters Overview 9

3 Products under Development 10

  • 3.1 Electrophysiology Ablation Catheters - Pipeline Products by Stage of Development 10
  • 3.2 Electrophysiology Ablation Catheters - Pipeline Products by Segment 11
  • 3.3 Electrophysiology Ablation Catheters - Pipeline Products by Territory 12
  • 3.4 Electrophysiology Ablation Catheters - Pipeline Products by Regulatory Path 13
  • 3.5 Electrophysiology Ablation Catheters - Pipeline Products by Estimated Approval Date 14
  • 3.6 Electrophysiology Ablation Catheters - Ongoing Clinical Trials 15

4 Electrophysiology Ablation Catheters - Pipeline Products under Development by Companies 16

  • 4.1 Electrophysiology Ablation Catheters Companies - Pipeline Products by Stage of Development 16
  • 4.2 Electrophysiology Ablation Catheters - Pipeline Products by Stage of Development 18

5 Electrophysiology Ablation Catheters Companies and Product Overview 20

  • 5.1 Ablacon Inc Company Overview 20
  • 5.2 Advanced Cardiac Therapeutics, Inc. Company Overview 21
  • 5.3 Apama Medical, Inc. Company Overview 24
  • 5.4 Biosense Webster Inc Company Overview 25
  • 5.5 BioTex Inc Company Overview 27
  • 5.6 Boston Scientific Corp Company Overview 29
  • 5.7 CardioFocus Inc Company Overview 36
  • 5.8 CardioNova Ltd Company Overview 41
  • 5.9 CathEffects LLC Company Overview 42
  • 5.10 CathRx Ltd Company Overview 43
  • 5.11 Cibiem Inc Company Overview 46
  • 5.12 Columbia University Company Overview 49
  • 5.13 Cordis Corp Company Overview 50
  • 5.14 CryoTherapeutics Gmbh Company Overview 51
  • 5.15 Epicardial Technologies Inc (Inactive) Company Overview 52
  • 5.16 FocusStart LLC Company Overview 53
  • 5.17 Interventional Imaging, Inc. Company Overview 54
  • 5.18 Iowa Approach Inc. Company Overview 55
  • 5.19 Maestro Heart SA Company Overview 58
  • 5.20 Mayo Clinic Company Overview 59
  • 5.21 Medlumics SL Company Overview 60
  • 5.22 MedWaves Inc Company Overview 61
  • 5.23 MicroPort Scientific Corp Company Overview 62
  • 5.24 North Carolina State University Company Overview 64
  • 5.25 Northwestern University Company Overview 65
  • 5.26 Novasentis Inc Company Overview 66
  • 5.27 SCR, Inc. Company Overview 67
  • 5.28 Seattle Children's Hospital Company Overview 68
  • 5.29 Sotera Medical Corp Company Overview 69
  • 5.30 St. Jude Medical LLC Company Overview 70
  • 5.31 Stereotaxis Inc Company Overview 71
  • 5.32 University of Michigan Company Overview 72
  • 5.33 University of Rochester Company Overview 73
  • 5.34 University of Texas Medical Branch at Galveston Company Overview 74
  • 5.35 Vanderbilt University Company Overview 75
  • 5.36 Vimecon GmbH Company Overview 76
  • 5.37 Vivonics, Inc. Company Overview 79
  • 5.38 Voyage Medical (Inactive) Company Overview 80

6 Electrophysiology Ablation Catheters- Recent Developments 81

  • 6.1 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results 81
  • 6.2 May 17, 2018: Mr. Jonathan Chen Promoted to Chief International Business Officer of MPSC 83
  • 6.3 May 09, 2018: CardioFocus Announces Successful Live Case Featuring HeartLight X3 System 83
  • 6.4 May 07, 2018: CardioFocus Announces FDA Approval Of The Next-Generation HeartLight Excalibur Balloon Designed For The Treatment Of Paroxysmal Atrial Fibrillation 84
  • 6.5 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy 85
  • 6.6 May 02, 2018: Biosense Webster Launches Study To Evaluate Novel High Power, Short Duration Modality For Treatment Of Atrial Fibrillation 85
  • 6.7 Apr 25, 2018: Boston Scientific Reports Financial Results For First Quarter 2018 86
  • 6.8 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics 88
  • 6.9 Mar 28, 2018: MicroPort Scientific Announces 2017 Annual Results 89
  • 6.10 Mar 27, 2018: MicroPort Scientific Announces Year Ended 31 December 2017 Financial Results 91
  • 6.11 Mar 19, 2018: Study Shows Positive Results with Medtronic Cryoballoon for Patients with Persistent Atrial Fibrillation 91
  • 6.12 Mar 06, 2018: Stereotaxis Reports 2017 Fourth Quarter And Full Year Financial Results 92
  • 6.13 Feb 26, 2018: CardioFocus Announces Initiation of HeartLight X3 Clinical Evaluation 94
  • 6.14 Feb 23, 2018: Atrial fibrillation patients benefit most from this treatment 95
  • 6.15 Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017 96
  • 6.16 Jan 31, 2018: First Triojection Cases in Germany were Recently Completed by Prof. Dr. Thomas Vogl MD 98
  • 6.17 Jan 31, 2018: Allegheny Health Network Neurosurgeons First in Region to Provide New Treatment for Painful Spinal Tumors 98
  • 6.18 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region 99
  • 6.19 Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017 99
  • 6.20 Jan 08, 2018: Stereotaxis Reports Preliminary Fourth Quarter 2017 Revenue Results 100
  • 6.21 Dec 19, 2017: Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region 100
  • 6.22 Nov 28, 2017: MedLumics Appoints Medtech Industry Veterans James Greene as Chief Executive Officer and Giovanni Leo as Member of the Board of Directors 101
  • 6.23 Nov 21, 2017: European doctors learn to access the heart from any approach with Baylis devices and expanded training program 102
  • 6.24 Nov 21, 2017: Medtronic Reports Second Quarter Financial Results 103
  • 6.25 Nov 09, 2017: Stereotaxis Reports Third Quarter 2017 Financial Results 106
  • 6.26 Nov 08, 2017: Medtronic Announces Preliminary Second Quarter Revenue 107
  • 6.27 Nov 02, 2017: Medtronic Releases Fiscal Year 2017 Integrated Performance Report 108
  • 6.28 Oct 26, 2017: Boston Scientific Announces Results For Third Quarter 2017 109
  • 6.29 Oct 25, 2017: Bard Announces Third Quarter Results 111
  • 6.30 Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria 112
  • 6.31 Oct 04, 2017: Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary 113
  • 6.32 Sep 27, 2017: CardioFocus Announces European CE Mark Approval Of The Next-Generation HeartLight Excalibur Balloon Designed For The Treatment Of Atrial Fibrillation 114
  • 6.33 Sep 11, 2017: MPSC Achieves Substantial Growth in 1H 2017 Net Profit Increases 272.4% YOY 114
  • 6.34 Sep 11, 2017: An opportunity to evaluate and speed-up new projects - Meet GE Healthcare at the Uppsala BIO booth 116
  • 6.35 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 117
  • 6.36 Aug 11, 2017: MPSC Issues Positive Profit Alert for 2017 1H Net Profit Expected to Increase 261% 119
  • 6.37 Aug 10, 2017: Stereotaxis Reports Second Quarter 2017 Financial Results 120
  • 6.38 Aug 01, 2017: FIRE AND ICE Trial Analysis Shows Medtronic Cryoballoon Reduces Healthcare System Costs and Utilization 121
  • 6.39 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017 122
  • 6.40 Jul 25, 2017: Catherine Estrampes appointed President & CEO of GE Healthcare Europe 124
  • 6.41 Jul 24, 2017: MicroPort Attends EUROPACE-CARDIOSTIM 2017 124
  • 6.42 Jul 11, 2017: Clinical Trial to Evaluate Medtronic Cryoablation as First-Line Treatment for Patients With Symptomatic Paroxysmal Atrial Fibrillation 125
  • 6.43 Jul 07, 2017: MPSC New COO Glendy Wang on Board 126
  • 6.44 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 126
  • 6.45 Jun 12, 2017: Kieran Murphy Appointed CEO of GE Healthcare, Succeeding John Flannery 128

7 Appendix 130

  • 7.1 Methodology 130
  • 7.2 About GlobalData 133
  • 7.3 Contact Us 133
  • 7.4 Disclaimer 133
Back to Top